Our intellectual property lawyers help the world's foremost companies use intellectual property to protect their investment, to secure and maintain competitive advantage and to obtain commercial outcomes. They have acted on some of the most complex disputes and transactions in the market.
Intellectual property is increasingly a differentiator amongst global businesses, and changes in the IP landscape are gathering pace. In competing for growth in mature markets, global players are looking to their brand and innovations to drive revenue.
Whether you are looking to monetise your innovations, protect revenue streams, or structure your intellectual property, our lawyers combine technical expertise and commercial nous to achieve the optimum outcomes for our clients. We help our clients commercialise and protect their innovations across sectors and continents, and are trusted with the most complex "bet the company" disputes and transactions.
We work in partnership with our clients to understand their businesses and where intellectual property adds value. In this way we are ready to provide strategic guidance as you navigate the global IP landscape, to help you avoid costly disputes and achieve favourable commercial outcomes. Where litigation is required, we bring to bear seamless global dispute resolution capability that is highly rated by our clients and in all major directories.
Diverse knowledge and in-depth expertise
Recent Experience
Gilead
Advising on global and UK proceedings in multiple patent actions against Idenix relating to its revolutionary Hepatitis C treatment, sofosbuvir
Sky
Advising on taking urgent legal action over the theft and use of customer data to recover the confidential data, including obtaining search orders, interim and final injunctions and freezing orders
NNB (EDF)
Advising on the IP aspects of arrangements relating to the construction of the next generation of nuclear plants in the UK with the UK Government - Hinkley Point C Nuclear Power Plant, the Sizewell C Project and the Bradwell B Project
AbbVie
Advising in a number of high value multi-jurisdictional actions concerning its blockbuster drug, Humira and its auto-injector delivery device
